The Ohio State University James Cancer Center, 412 — Columbus, Ohio

The Ohio State University James Cancer Center, 412 is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

The Ohio State University James Cancer Center, 412 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma.

Sponsors: OncoC4, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Ohio State University James Cancer Center, 412?

The Ohio State University James Cancer Center, 412 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Ohio State University James Cancer Center, 412 conducted?

The Ohio State University James Cancer Center, 412 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma.

Is The Ohio State University James Cancer Center, 412 accredited by Crixeo Health?

The Ohio State University James Cancer Center, 412 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Ohio State University James Cancer Center, 412?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.